Method for treating tumor using irradiated tumor cell expressing human hepatitis b surface antigen and a pharmaceutical composition comprising the tumor cell
OwnerSeok Koo Choinventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for treating a tumor in mammals comprising administering tumor cells in a therapeutically effective amount, in which the tumor cells lose their proliferative function by irradiation, are genetically manipulated to express hepatitis B surface antigen and are the same as the tumor to be treated, and a pharmaceutical composition for treatment of a tumor comprising the tumor cells.
Claims16
A method for treating tumor in mammals comprising administering tumor cells in a therapeutically effective amount, in which the tumor cells lose their proliferative function by irradiation, are genetically manipulated to express hepatitis B surface antigen and are the same as the tumor to be treated.
A pharmaceutical composition for treatment of a tumor in mammals comprising tumor cells which express hepatitis B surface antigen and lose their proliferative function by irradiation, and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.